horizon pharma plc (HZNP:NASDAQ GS)
Jeffrey W. Sherman M.D., FACP
Chief Medical Officer and Executive Vice President of Research & Development, Horizon Pharma plc
|Age||Total Calculated Compensation||This person is connected to 4 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Jeffrey W. Sherman, M.D., F.A.C.P. has been Chief Medical Officer and Executive Vice President of Research and Development at Horizon Pharma plc since March 2010 and Horizon Pharma USA, Inc since June 2009 and September 2014 respectively. Dr. Sherman served as Executive Vice President of Development and Regulatory Affairs at Horizon Pharma plc since June 2009. Dr. Sherman served as Executive Vice President of Development, Regulatory Affairs, Manufacturing at Horizon ...
Connaught HousePhone: 353 1 772 2100
Dublin, -- 4
Board Members Memberships*
President of Board of Directors
Rosalind Franklin University of Medicine and Science
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Rajiv Kanishka Liyanaarchchie De Silva||Chief Executive Officer, President and Director|
Endo International plc
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.8M||Compensation as of Fiscal Year 2014.|